Position in CDNA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$57,513
+$22,481 QoQ
Shares Held
2,018
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#180
of 225 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026KBC Group NV holds $446,284,356 across 25 Diagnostics & Research names. CDNA ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IQV |
Iqvia Holdings Inc.
|
747,974 | $144,523,534 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
197,810 | $99,174,020 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
113,614 | $59,810,953 | |
| 4 | DHR |
Danaher Corp /De/
|
268,957 | $51,230,928 | |
| 5 | LH |
Labcorp Holdings Inc.
|
105,543 | $29,552,040 | |
| 6 | DGX |
Quest Diagnostics Inc
|
54,912 | $11,638,597 | |
| 7 | A |
Agilent Technologies, Inc.
|
81,883 | $10,876,518 | |
| 8 | ILMN |
Illumina, Inc.
|
54,388 | $9,563,041 |
All Filings in CDNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,513 | 2,018 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $35,032 | 2,018 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $66,429 | 3,526 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $51,268 | 3,526 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $20,204 | 1,034 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $56,267 | 3,170 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $67,869 | 3,170 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $98,983 | 3,170 | Shares | Defined | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||